Please turn JavaScript on
Medicines and Healthcare products Regulatory Agency - Activity on GOV.UK icon

Medicines and Healthcare products Regulatory Agency - Activity on GOV.UK

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.61 / day

Message History

Healthy weight loss takes time, not shortcuts. As demand for weight-loss medicines continues to rise, the MHRA is reminding people how to use GLP-1 medicines safely, spot illegal sellers and avoid diet changes that could interfere with their medicines.

Read full story
Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg and 40mg chewable tablets.

Read full story
Information about how we handle potential corporate conflicts of interest (COI) between different parts of the Agency.

Read full story
The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of episodes of severe hypertension.

Read full story
The new inhalers use a next-generation propellant designed to reduce environmental impact while maintaining the same established treatment.

Read full story